Arbutus Biopharma Ownership | Who Owns Arbutus Biopharma?
Arbutus Biopharma Ownership Summary
Arbutus Biopharma is owned by 16.26% institutional investors, 21.89% insiders, and 61.84% retail investors. Morgan stanley is the largest institutional shareholder, holding 11.93% of ABUS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.57% of its assets in Arbutus Biopharma shares.
ABUS Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Arbutus Biopharma | 16.26% | 21.89% | 61.84% |
Sector | Healthcare Stocks | 279.19% | 10.62% | -189.81% |
Industry | Biotech Stocks | 63.96% | 10.74% | 25.30% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Morgan stanley | 20.96M | 11.93% | $64.77M |
Whitefort capital management, lp | 13.31M | 7.17% | $46.44M |
Blackrock funding, inc. /de | 12.94M | 6.85% | $42.31M |
Blackrock | 11.55M | 6.58% | $35.70M |
Two seas capital lp | 9.47M | 5.10% | $33.04M |
Vanguard group | 8.98M | 4.75% | $29.37M |
State street | 5.03M | 2.66% | $16.44M |
Geode capital management | 3.48M | 1.84% | $11.39M |
Foursixthree capital lp | 2.45M | 1.32% | $8.55M |
Blackbarn capital partners lp | 2.34M | 1.24% | $7.66M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Whitefort capital management, lp | 13.31M | 21.85% | $46.44M |
Corbin capital partners | 682.49K | 3.64% | $2.23M |
Fourworld capital management | 1.23M | 2.75% | $4.28M |
Foursixthree capital lp | 2.45M | 2.36% | $8.55M |
Adar1 capital management | 1.88M | 1.22% | $6.56M |
Two seas capital lp | 9.47M | 1.04% | $33.04M |
Stempoint capital lp | 467.88K | 0.52% | $1.63M |
Blackbarn capital partners lp | 2.34M | 0.42% | $7.66M |
Saba capital management | 979.52K | 0.09% | $3.42M |
Quinn opportunity partners | 404.88K | 0.09% | $1.32M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Morgan stanley | 20.96M | 0.01% | 12.13M |
Foursixthree capital lp | 2.45M | 2.36% | 2.45M |
Blackrock | 11.55M | 0.00% | 1.15M |
Jpmorgan chase | 896.26K | 0.00% | 806.67K |
Two seas capital lp | 9.47M | 1.04% | 725.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Adage capital partners gp | 1.65M | 0.01% | -1.25M |
Boothbay fund management | 162.28K | 0.01% | -450.00K |
Corbin capital partners | 682.49K | 3.64% | -170.82K |
Lmr partners llp | - | - | -158.25K |
Lighthouse investment partners | - | - | -99.06K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Foursixthree capital lp | 2.45M | 2.36% | 2.45M | $8.55M |
Stempoint capital lp | 467.88K | 0.52% | 467.88K | $1.63M |
Susquehanna fundamental investments | 202.54K | 0.01% | 202.54K | $662.31K |
Franklin resources | 92.16K | 0.00% | 92.16K | $301.36K |
Caption management | 69.60K | 0.00% | 69.60K | $227.59K |
Sold Out
Holder | Change |
---|---|
Federated hermes | -3.00 |
Nelson, van denburg & campbell wealth management group | -24.00 |
Opal wealth advisors | -100.00 |
Central trust | -100.00 |
Capital performance advisors llp | -545.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 9 | -94.48% | 30,187,875 | -70.98% | 16 | 0.54% | 8 | -89.19% | - | -100.00% |
Dec 31, 2024 | 161 | 5.23% | 103,747,487 | 2.96% | 54 | 1.93% | 73 | -5.19% | 44 | 41.94% |
Sep 30, 2024 | 153 | 12.50% | 100,767,700 | 4.58% | 53 | 2.03% | 77 | 8.45% | 31 | 3.33% |
Jun 30, 2024 | 135 | 5.47% | 96,359,003 | 16.04% | 54 | 2.19% | 71 | 26.79% | 30 | -6.25% |
Mar 31, 2024 | 128 | 4.92% | 83,042,471 | 5.67% | 50 | 2.27% | 56 | 7.69% | 32 | 14.29% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 4.92M | 2.57% | - |
Vanguard Total Stock Mkt Idx Inv | 4.87M | 2.54% | - |
Morgan Stanley Insight A | 4.24M | 2.23% | 399.58K |
Morgan Stanley Insight | 4.20M | 2.19% | -47.11K |
Morgan Stanley Insight I | 4.20M | 2.19% | -47.11K |
iShares Russell 2000 ETF | 3.75M | 1.96% | 1.84K |
MS INVF Global Insight Z | 2.50M | 1.31% | - |
Vanguard Institutional Extnd Mkt Idx Tr | 2.35M | 1.23% | 5.79K |
Morgan Stanley Inst Inception I | 2.13M | 1.11% | -157.50K |
Morgan Stanley Inception | 2.13M | 1.11% | -157.50K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Feb 04, 2025 | HASTINGS DAVID C | Chief Financial Officer | Sell | $72.83K |
Feb 04, 2025 | Sims Karen | Chief Medical Officer | Sell | $63.52K |
Feb 04, 2025 | McElhaugh Michael J. | Interim President & CEO | Sell | $78.10K |
Feb 04, 2025 | Naftzger J. Christopher | General Counsel and CCO | Sell | $37.21K |
Aug 14, 2024 | MANCHESTER KEITH S | - | Sell | $32.64K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 4 |
2024 Q3 | - | 1 |
2024 Q2 | - | - |
2024 Q1 | - | 4 |
2023 Q3 | - | - |
ABUS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools